Acute Coronary Syndrome Therapy
Studies from University of Maryland in the area of acute coronary syndrome therapy published
Published in Obesity and Diabetes Week, April 26th, 2010
Scientists discuss in 'Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes' new findings in acute coronary syndrome. "UCP2 -866G >A (rs659366) has been implicated in cardiometabolic disease and represents a novel candidate gene for beta-blocker response, particularly among patients with diabetes. We assessed the function of -866G >A and its role as a modifier of beta-blocker treatment outcomes by diabetes status in an acute coronary syndrome (ACS) cohort," scientists in the United States report.
"ACS patients with genetic samples and 12 months of follow-up for cardiac rehospitalizations...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Beth Israel Deaconess Medical Center
New form of endoscopic scanning improves detection of precancerous condition - Oregon Health & Science University
Diet alone will not likely lead to significant weight loss - University of California - San Francisco
Childhood obesity interventions must begin early, UCSF experts say - Body Weight
Scientists at Kyungpook National University publish new data on body weight - Breast Cancer
New findings from A.K. Imkampe and co-authors in the area of breast cancer published - Breast Cancer
Studies from University of Minnesota provide new data on breast cancer - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
